December 9, 2010 Martha Brumfield, PhD, Hired as Director, International Programs Martha Brumfield, PhD, has joined Critical Path Institute (C-Path) as Director of International Programs.
November 11, 2010 Leading Pharmacologist and Pharmaceutical Scientist Joins Critical Path Institute Thorir D. Bjornsson, MD, PhD, has joined Critical Path Institute as a member of its Board of Directors, and will also lead one of
November 11, 2010 Leading Neuroscientist Joins Critical Path Institute Marc Cantillon, MD, has joined Critical Path Institute as Executive Director of one of its major consortia, the Coalition Against
October 11, 2010 Manuscript on Current State of Pharmacometrics in Special Issue of Journal of Clinical Pharmacology Co-authored by C-Path’s Klaus Romero, MS, MD Recently Released Pharmacometrics as a Discipline Is Entering the “Industrialization” Phase: Standards, Automation, Knowledge Sharing, a
October 11, 2010 Raymond Woosley, MD, PhD, C-Path President/CEO to present keynote address at CDISC North American Exchange November 1-5, 2010 in Baltimore, MD The CDISC Board of Directors and Dr. Rebecca Kush, President & CEO are pleased to announce three exceptional keynote speakers
October 10, 2010 Governor Brewer Awards $2.2 Million in Stimulus Dollars Towards Creation of New Biomedical Research Resource in Arizona Science Foundation Arizona selects Tucson based Critical Path Institute and collaborator, Roche’s Ventana Medical Systems, t
October 5, 2010 Urinary Clusterin, Cystatin C, [beta]2-Microglobulin and Total Protein as Markers to Detect Drug-Induced Kidney Injury
October 5, 2010 Renal Biomarker Qualification Submission: A Dialog Between the FDA-EMEA and Predictive Safety Testing Consortium